Literature DB >> 23365087

TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15.

Suaad Ahmed1, Ashwini Maratha, Aisha Qasim Butt, Enda Shevlin, Sinead M Miggin.   

Abstract

TLRs are a group of pattern-recognition receptors that play a crucial role in danger recognition and induction of the innate immune response against bacterial and viral infections. The TLR adaptor molecule, Toll/IL-1R domain-containing adaptor inducing IFN (TRIF), facilitates TLR3 and TLR4 signaling and concomitant activation of the transcription factors, NF-κB and IFN regulatory factor 3, leading to proinflammatory cytokine production. Whereas numerous studies have been undertaken toward understanding the role of TRIF in TLR signaling, little is known about the signaling components that regulate TRIF-dependent TLR signaling. To this end, TRIF-interacting partners were identified by immunoprecipitation of the TRIF signaling complex, followed by protein identification using liquid chromatography mass spectrometry. Following stimulation of cells with a TLR3 or TLR4 ligand, we identified a disintegrin and metalloprotease (ADAM)15 as a novel TRIF-interacting partner. Toward the functional characterization of the TRIF:ADAM15 interaction, we show that ADAM15 acts as a negative regulator of TRIF-mediated NF-κB and IFN-β reporter gene activity. Also, suppression of ADAM15 expression enhanced polyriboinosinic polyribocytidylic acid and LPS-mediated proinflammatory cytokine production via TRIF. In addition, suppression of ADAM15 expression enhanced rhinovirus 16 and vesicular stomatitis virus-mediated proinflammatory cytokine production. Interestingly, ADAM15 mediated the proteolytic cleavage of TRIF. Thus, ADAM15 serves to curtail TRIF-dependent TLR3 and TLR4 signaling and, in doing so, protects the host from excessive production of proinflammatory cytokines and matrix metalloproteinases. In conclusion, to our knowledge, our study clearly shows for the first time that ADAM15 plays an unexpected role in TLR signaling, acting as an anti-inflammatory molecule through impairment of TRIF-mediated TLR signaling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365087     DOI: 10.4049/jimmunol.1201630

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Systems biology unravels interferon responses to respiratory virus infections.

Authors:  Andrea L Kroeker; Kevin M Coombs
Journal:  World J Biol Chem       Date:  2014-02-26

Review 2.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

3.  Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.

Authors:  S Kusaka; A Nishida; K Takahashi; S Bamba; H Yasui; M Kawahara; O Inatomi; M Sugimoto; A Andoh
Journal:  Clin Exp Immunol       Date:  2017-09-28       Impact factor: 4.330

4.  TLR3 signaling is downregulated by a MAVS isoform in epithelial cells.

Authors:  Omar Lakhdari; Christopher S McAllister; Michael Wang; Ivelina Minev; Lawrence S Prince; Lars Eckmann; Martin F Kagnoff
Journal:  Cell Immunol       Date:  2016-08-24       Impact factor: 4.868

5.  MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability.

Authors:  Yang Sun; Zhen Qin; Qi Li; Jing-Jing Wan; Ming-He Cheng; Peng-Yuan Wang; Ding-Feng Su; Jian-Guang Yu; Xia Liu
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

6.  Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor.

Authors:  Siddhartha S Saha; Divyendu Singh; Ernest L Raymond; Rajkumar Ganesan; Gary Caviness; Christine Grimaldi; Joseph R Woska; Detlev Mennerich; Su-Ellen Brown; M Lamine Mbow; C Cheng Kao
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

7.  Protection of toll-like receptor 9 against lipopolysaccharide-induced inflammation and oxidative stress of pulmonary epithelial cells via MyD88-mediated pathways.

Authors:  Zhenhong Qi; Zhijie He; Jiaxin Chen; Mingyuan Ma; Menghua Deng; Yunhai Zhang; Tianwei Ma
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

Review 8.  Toll-like receptor 3 in viral pathogenesis: friend or foe?

Authors:  Renzo Perales-Linares; Sonia Navas-Martin
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 9.  Type I interferons as regulators of human antigen presenting cell functions.

Authors:  Sandra Gessani; Lucia Conti; Manuela Del Cornò; Filippo Belardelli
Journal:  Toxins (Basel)       Date:  2014-05-26       Impact factor: 4.546

10.  The TIR-domain containing adaptor TRAM is required for TLR7 mediated RANTES production.

Authors:  Enda Shevlin; Sinéad M Miggin
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.